Global Retirement Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.14M Sell
145,171
-35,011
-19% -$931K 0.06% 281
2026
Q2
$4.34M Sell
180,182
-36,320
-17% -$950K 0.07% 268
2025
Q4
$5.39M Buy
216,502
+81,713
+61% +$2.06M 0.1% 196
2025
Q3
$3.43M Sell
134,789
-1,068
-0.8% -$26.4K 0.08% 238
2025
Q2
$3.29M Buy
135,857
+31,272
+30% +$729K 0.08% 225
2024
Q4
$2.77M Sell
104,585
-24,744
-19% -$671K 0.08% 240
2024
Q3
$3.74M Sell
129,329
-116
-0.1% -$3.38K 0.11% 175
2024
Q2
$3.62M Buy
129,445
+24,709
+24% +$680K 0.11% 180
2024
Q1
$2.91M Buy
104,736
+6,774
+7% +$188K 0.11% 188
2023
Q4
$2.77M Sell
97,962
-5,740
-6% -$174K 0.12% 176
2023
Q3
$3.45M Sell
103,702
-6,961
-6% -$246K 0.17% 119
2023
Q2
$4.06M Buy
110,663
+11,735
+12% +$457K 0.2% 112
2023
Q1
$3.8M Buy
98,928
+8,437
+9% +$364K 0.2% 111
2022
Q4
$4.64M Buy
90,491
+7,927
+10% +$380K 0.32% 66
2022
Q3
$3.84M Buy
82,564
+4,719
+6% +$229K 0.29% 76
2022
Q2
$4.08M Buy
77,845
+311
+0.4% +$15.8K 0.33% 72
2022
Q1
$4.14M Buy
77,534
+21,232
+38% +$1.1M 0.33% 69
2021
Q4
$3.32M Sell
56,302
-2,107
-4% -$104K 2.57% 9
2021
Q3
$2.51M Buy
58,409
+917
+2% +$40.6K 0.25% 86
2021
Q2
$2.25M Buy
57,492
+1,098
+2% +$42.7K 0.23% 97
2021
Q1
$2.04M Buy
56,394
+557
+1% +$19.8K 0.24% 87
2020
Q4
$2.06M Sell
55,837
-4,931
-8% -$181K 0.26% 75
2020
Q3
$2.23M Buy
60,768
+1,748
+3% +$64.6K 0.33% 66
2020
Q2
$1.93M Sell
59,020
-628
-1% -$22.5K 0.31% 62
2020
Q1
$1.95M Sell
59,648
-6,171
-9% -$222K 0.37% 57
2019
Q4
$2.58M Buy
65,819
+95
+0.1% +$3.57K 0.4% 53
2019
Q3
$2.36M Buy
65,724
+21,459
+48% +$822K 0.39% 56
2019
Q2
$1.92M Buy
44,265
+9,750
+28% +$408K 0.37% 54
2019
Q1
$1.47M Sell
34,515
-575
-2% -$24.3K 0.35% 56
2018
Q4
$1.53M Sell
35,090
-148
-0.4% -$6.48K 0.39% 57
2018
Q3
$1.55M Sell
35,238
-36
-0.1% -$1.46K 0.35% 60
2018
Q2
$1.28M Buy
35,274
+411
+1% +$14.8K 0.32% 59
2018
Q1
$1.24M Sell
34,863
-5,297
-13% -$192K 0.34% 59
2017
Q4
$1.46M Buy
40,160
+17,272
+75% +$621K 0.4% 39
2017
Q3
$817K Buy
22,888
+1,508
+7% +$51.1K 0.34% 54
2017
Q2
$718K Buy
21,380
+3,290
+18% +$109K 0.34% 55
2017
Q1
$619K Buy
18,090
+1,001
+6% +$33.3K 0.35% 56
2016
Q4
$555K Hold
17,089
– – 0.37% 52

Other funds holding PFE

Global Retirement Partners's PFE Position: Q3 2026 in Review

Global Retirement Partners reduced its Pfizer (PFE) stake by 19% in Q3 2026, selling an estimated $931K and leaving 145,171 shares worth $4.14M. The position accounts for 0.06% of the portfolio, ranked #281.

Global Retirement Partners first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $5.39M in Q4 2025. 2,918 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Global Retirement Partners held 145,171 shares of Pfizer worth $4.14M as of Q3 2026.
  • Global Retirement Partners sold 35,011 Pfizer shares in Q3 2026, an estimated $931K.
  • Pfizer made up 0.06% of Global Retirement Partners's portfolio in Q3 2026, its #281 holding.
  • Global Retirement Partners first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
  • Global Retirement Partners's Pfizer position peaked at $5.39M in Q4 2025.
  • 2,918 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.